362 related articles for article (PubMed ID: 27454866)
1. Kupffer Cells Undergo Fundamental Changes during the Development of Experimental NASH and Are Critical in Initiating Liver Damage and Inflammation.
Reid DT; Reyes JL; McDonald BA; Vo T; Reimer RA; Eksteen B
PLoS One; 2016; 11(7):e0159524. PubMed ID: 27454866
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
[TBL] [Abstract][Full Text] [Related]
3. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
4. Involvement of resistin-like molecule β in the development of methionine-choline deficient diet-induced non-alcoholic steatohepatitis in mice.
Okubo H; Kushiyama A; Sakoda H; Nakatsu Y; Iizuka M; Taki N; Fujishiro M; Fukushima T; Kamata H; Nagamachi A; Inaba T; Nishimura F; Katagiri H; Asahara T; Yoshida Y; Chonan O; Encinas J; Asano T
Sci Rep; 2016 Jan; 6():20157. PubMed ID: 26818807
[TBL] [Abstract][Full Text] [Related]
5. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.
Tosello-Trampont AC; Landes SG; Nguyen V; Novobrantseva TI; Hahn YS
J Biol Chem; 2012 Nov; 287(48):40161-72. PubMed ID: 23066023
[TBL] [Abstract][Full Text] [Related]
6. Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis.
Wang X; Hausding M; Weng SY; Kim YO; Steven S; Klein T; Daiber A; Schuppan D
Antioxid Redox Signal; 2018 Jan; 28(2):87-109. PubMed ID: 28635324
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model.
Van Campenhout S; Tilleman L; Lefere S; Vandierendonck A; Raevens S; Verhelst X; Geerts A; Van Nieuwerburgh F; Van Vlierberghe H; Devisscher L
Metabolism; 2020 Jun; 107():154220. PubMed ID: 32243868
[TBL] [Abstract][Full Text] [Related]
8. Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice.
Jeurissen ML; Walenbergh SM; Houben T; Hendrikx T; Li J; Oligschlaeger Y; van Gorp PJ; Gijbels MJ; Bitorina A; Nessel I; Radtke F; Vooijs M; Theys J; Shiri-Sverdlov R
PLoS One; 2016; 11(11):e0167199. PubMed ID: 27898698
[TBL] [Abstract][Full Text] [Related]
9. Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis.
Seidman JS; Troutman TD; Sakai M; Gola A; Spann NJ; Bennett H; Bruni CM; Ouyang Z; Li RZ; Sun X; Vu BT; Pasillas MP; Ego KM; Gosselin D; Link VM; Chong LW; Evans RM; Thompson BM; McDonald JG; Hosseini M; Witztum JL; Germain RN; Glass CK
Immunity; 2020 Jun; 52(6):1057-1074.e7. PubMed ID: 32362324
[TBL] [Abstract][Full Text] [Related]
10. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
11. Dietary Lipids Differentially Shape Nonalcoholic Steatohepatitis Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages.
McGettigan B; McMahan R; Orlicky D; Burchill M; Danhorn T; Francis P; Cheng LL; Golden-Mason L; Jakubzick CV; Rosen HR
Hepatology; 2019 Jul; 70(1):67-83. PubMed ID: 30516830
[TBL] [Abstract][Full Text] [Related]
12. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.
Miura K; Yang L; van Rooijen N; Ohnishi H; Seki E
Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1310-21. PubMed ID: 22442158
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic steatohepatitis induces transient changes within the liver macrophage pool.
Devisscher L; Scott CL; Lefere S; Raevens S; Bogaerts E; Paridaens A; Verhelst X; Geerts A; Guilliams M; Van Vlierberghe H
Cell Immunol; 2017 Dec; 322():74-83. PubMed ID: 29111158
[TBL] [Abstract][Full Text] [Related]
14. Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease.
Luo W; Xu Q; Wang Q; Wu H; Hua J
Sci Rep; 2017 Mar; 7():44612. PubMed ID: 28300213
[TBL] [Abstract][Full Text] [Related]
15. Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).
Jindal A; Bruzzì S; Sutti S; Locatelli I; Bozzola C; Paternostro C; Parola M; Albano E
Exp Mol Pathol; 2015 Aug; 99(1):155-62. PubMed ID: 26112094
[TBL] [Abstract][Full Text] [Related]
16. Roles of Macrophages in Advanced Liver Fibrosis, Identified Using a Newly Established Mouse Model of Diet-Induced Non-Alcoholic Steatohepatitis.
Tada Y; Kasai K; Makiuchi N; Igarashi N; Kani K; Takano S; Honda H; Yanagibashi T; Watanabe Y; Usui-Kawanishi F; Furusawa Y; Ichimura-Shimizu M; Tabuchi Y; Takatsu K; Tsuneyama K; Nagai Y
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362037
[TBL] [Abstract][Full Text] [Related]
17. Intravital imaging of interactions between iNKT and kupffer cells to clear free lipids during steatohepatitis.
Wang H; Li L; Li Y; Li Y; Sha Y; Wen S; You Q; Liu L; Shi M; Zhou H
Theranostics; 2021; 11(5):2149-2169. PubMed ID: 33500717
[No Abstract] [Full Text] [Related]
18. RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr
Bijnen M; Beelen N; Wetzels S; Gaar JV; Vroomen M; Wijnands E; Scheijen JL; van de Waarenburg MPH; Gijbels MJ; Cleutjens JP; Biessen EAL; Stehouwer CDA; Schalkwijk CG; Wouters K
Sci Rep; 2018 Oct; 8(1):15256. PubMed ID: 30323247
[TBL] [Abstract][Full Text] [Related]
19. Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis.
Krenkel O; Hundertmark J; Abdallah AT; Kohlhepp M; Puengel T; Roth T; Branco DPP; Mossanen JC; Luedde T; Trautwein C; Costa IG; Tacke F
Gut; 2020 Mar; 69(3):551-563. PubMed ID: 31076404
[TBL] [Abstract][Full Text] [Related]
20. HSPA12A Is a Novel Player in Nonalcoholic Steatohepatitis via Promoting Nuclear PKM2-Mediated M1 Macrophage Polarization.
Kong Q; Li N; Cheng H; Zhang X; Cao X; Qi T; Dai L; Zhang Z; Chen X; Li C; Li Y; Xue B; Fang L; Liu L; Ding Z
Diabetes; 2019 Feb; 68(2):361-376. PubMed ID: 30455376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
